Antares Pharma, Inc. announced that it has filed a New Drug Application with the U.S. Food and Drug Administration for Anturol Gel in patients with overactive bladder.
In a breakthrough that could lead to new treatments for patients with melanoma, researchers have discovered that a particular protein suppresses the progression of melanoma through regulation of an oncogene, or gene responsible for cancer growth.
Researchers have discovered how HIV binds to and destroys a specific human antiviral protein called APOBEC3F. The results suggest that a simple chemical change can convert APOBEC3F to a more effective antiviral agent.
In three monthly injections, researchers transplanted neurally-committed, autologous cord blood derived cells tagged with iron oxide nanoparticles into the lateral cerebral ventricle of a 16-month old child with severe global hypoxic ischemic brain injury.
By determining how corticosteroids act to promote red blood cell progenitor formation, researchers have identified a class of drugs that may be beneficial in anemias, including those resulting from trauma, sepsis, malaria, kidney dialysis, and chemotherapy.
Oxford BioMedica plc announces new data from the on-going Phase 1/2 trial of ProSavin for the treatment of Parkinson’s disease. Three-month data from the third patient cohort show that ProSavin continues to be safe and well-tolerated.
Bristol-Myers Squibb Company and Pfizer Inc. announced study results showing apixaban was statistically superior to 40 mg daily enoxaparin in reducing the incidence of venous thromboembolism in patients undergoing elective total hip replacement surgery.
AstraZeneca PLC and Abbott Laboratories said they are ending a partnership on a cholesterol drug that was rejected by the Food and Drug Administration earlier this year.
Gilead Sciences, Inc. announced it is stopping ARTEMIS-IPF, the company's Phase 3 clinical trial of ambrisentan in patients with idiopathic pulmonary fibrosis, due to lack of efficacy.
Novartis AG said the Food and Drug Administration approved Amturnide, a high blood pressure combination pill that includes Novartis' drug Tekturna.
The Food and Drug Administration said that Abbott Laboratories is recalling up to 359 million testing strips used by diabetics because they can give falsely low blood sugar readings.
Eli Lilly and Co. and Amylin Pharmaceuticals Inc. said they are asking the Food and Drug Administration to expand approval for their type 2 diabetes drug Byetta.
Two Fold Software Limited has created a web reporting module for its Qualoupe LIMS solution that allows organisations such as contract laboratories or manufacturing companies to access and run LIMS reports on demand in a more cost-efficient way.
SGE Analytical Science has been awarded a grant to help develop a new diamond-like coating technology. Diamond-like coating technology, or plasma-activated high-frequency vacuum deposition, has low friction and is extremely durable.
Merrion Pharmaceuticals Plc announced the signing of a Collaboration and Option agreement with Novo Nordisk. The agreement will evaluate the ability of Merrion's patented GIPET technology to boost the oral bioavailability of an undisclosed compound.